Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SETD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NSFL1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927673 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NGDN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDHA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF836 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IFT43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CARS-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
EXOC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FKBPL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHMP2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KAT5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC7A8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATG13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR1282 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on